key: cord-0701656-gsnq4oih authors: Lim, Jia Xu; Leong, Adriel Z.; Tan, Choo Heng; Teo, Kejia; Nga, Vincent D.W.; Lwin, Sein; Chou, Ning; Yeo, Tseng Tsai title: Coronavirus Disease 2019 (COVID-19) Response Measures—A Singapore Neurosurgical Academic Medical Center Experience in Emerging from the Worldwide Pandemic date: 2020-09-23 journal: World Neurosurg DOI: 10.1016/j.wneu.2020.07.159 sha: 16a500efc81fb972a12abc5318b69a5f6da59ee7 doc_id: 701656 cord_uid: gsnq4oih nan Jia Xu Lim 1,2 , Adriel Z. Leong It is almost 7 months since the novel coronavirus disease 2019 (COVID-19) began spreading from Wuhan province in China 1 and 6 months after Singapore's first imported case of COVID-19, 2 4 months from which the virus was declared a pandemic by the World Health Organization 3 and 3 months since implementing the segregated team model in response. 4 During this period, major strides have been made to better understand the virus, including its neurologic manifestations and impact on neurosurgery, 5,6 its treatment, 7 and vaccination. 8 Singapore has also lifted her "circuit breaker" (lockdown) restrictions, in phases, starting from June 1, 2020. 9 This is a follow-up article reflecting on the impact of COVID-19 on neurosurgical service provision, our response, and our results thus far. We have responded to the loosening of restrictions and settling into the new routine with the re-establishment of our educational forums in addition to elective and outpatient services. Regular journal clubs, residents' tutorials, and multidisciplinary meetings, albeit via teleconferencing, have resumed. The bevy of international conferences now delivered to our doorstep via videoconferences are included into our mandatory educational curriculum. Combined teaching for the nation's 2 neurosurgical training programs has also become the norm. The past 3 months have tightened up various implemented processes. These include the functioning and efficiency of our COVID-19 suspect emergency operating theater (EOT)-a theater fully equipped with advanced surgical and microsurgical capabilities, in a negatively pressurized room, with a separate entrance and route from the emergency department. The original standard personal protective equipment has also been upgraded to include powered air-purifying respirator. This improves the comfort and maneuverability of the surgeon, which in turn improves surgical efficiency. Our teleconferencing procedures have also been streamlined with the addition of professional video-conferencing hardware and software that allows interface between the Internet and conferencing application with our intranet, electronic documentation, and neuroimaging software to enable a seamless experience from the comfort of the office or even home. As we look forward to the resumption of clinical work performed in the familiar consultant-led team-based model (the segregation model is slated to end in August 2020 should the trajectory of COVID-19 cases in Singapore remain under control), we reflect on how our segregation model performed. Under this model, each team manages either inpatient or outpatient duties and alternates on a weekly basis. As the inpatient responsibilities are generally much heavier, while managing outpatient duties, enforced rest is mandated on non-clinic days and weekends. In the last 3 months, we managed to maintain a busy inpatient and outpatient service while preserving an adequate work rest cycle for the service ( Table 1) . During this period, we performed 16 surgeries on patients with suspected and confirmed COVID-19 in the COVID-19 EOT, including clipping of complex aneurysms, clot evacuations, and decompressive craniectomies for COVID-19erelated malignant infarcts. We have also managed more than 30 suspected and confirmed patients with COVID-19 in the wards. To minimize community and cross-institution transmission, our patients undergo COVID-19 testing before discharge to subacute or rehabilitation facilities. Concerning the conduct of emergency surgeries, the assumption that every emergency patient is a potential patient with COVID-19 was held, even if they did not fulfill the criteria for being operated in the COVID-19 EOT. Hence, in addition to the usual surgical aims, we aimed to limit exposure and contact time. This has translated to an increased consultant involvement and rise in use of hemostatic agents such as FLOSEAL. The rescheduling of elective neurosurgical cases is now allowed. We have also resumed the provision of elective endoscopic transsphenoidal surgery. This high risk 10 is mitigated by ensuring a negative COVID-19 swab before proceeding. We are also ramping up the outpatient services by increasing the scheduling of first visit consultations and being more liberal with follow-up visits ( Table 2) . With all these, the workload is expected to rise back up to previous levels. To further cope with the rising demand, new directions such as telemedicine is considered for a select group of neurosurgical patients. We are fortunate with our measures; thus far, there has been no cases of suspected COVID-19 infection among the faculty and residents thus far. As we reflect on team-segregation model provision of clinical services, we were fortunate to have had no COVID-19erelated incidents or near-misses and ensured that all clinical medical staff remained COVID-19 free. The provision of neurosurgical services was smooth, and we managed to further refine our operative, educational, and administrative processes while ensuring sufficient rest for clinical staff. As we take the first steps toward a cautious reopening, we remain wary and vigilant of the possibility of a second and third wave and conserve capacity and flexibility to return to previous segregation model if required, which has proven to be successful thus far. As we grapple with the new normal, it is becoming more evident that change is the only constant. We need to continuously evolve and adapt to keep up, acclimatize, and overcome both predictable and unforeseen challenges and obstacles that will inevitably come our way. A pneumonia outbreak associated with a new coronavirus of probable bat origin COVID-10 in Singapore-current experience: critical global issues that require attention and action World Health Organization. Coronavirus disease (COVID-19) pandemic COVID-19 response measures-a Singapore neurosurgical academic medical centre experience segregated team model to maintain tertiary level neurosurgical care during the COVID-19 outbreak Neurological manifestations of COVID-19 and other coronavirus infections: a systemic review Risk of ischaemic stroke in patients with coronavirus disease 2019 (COVID-19) vs patients with influenza Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19 Coronavirus vaccine tracker. The New York Times COVID-19: how Singapore will exit the circuit breaker in 3 phases after COVID-19 and neurosurgery. American Association of Neurological Surgeons Singapore 1878-8750/$ -see front matter ª